ZHUYONG MEI to Cell Line, Tumor
This is a "connection" page, showing publications ZHUYONG MEI has written about Cell Line, Tumor.
Connection Strength
0.025
-
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood. 2011 Dec 01; 118(23):6050-6.
Score: 0.015
-
Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin. J Immunother. 2007 Feb-Mar; 30(2):227-33.
Score: 0.011